Rectal Cancer

• DOI: 10.6004/jnccn.2012.0158
• Publication Date: 2017-04-14T12:00:59Z
• Authors: Al B. Benson; Tanios Bekaii-Saab; Emily Chan; Yi-Jen Chen; Michael A. Choti; Harry S. Cooper; Paul F. Engstrom; Peter C. Enzinger; Marwan G. Fakih; Charles S. Fuchs; Jean L. Grem; Steven Hunt; Lucille A. Leong; Edward Lin; Michael G. Martin; Kilian Salerno May; Mary F. Mulcahy; Kate Murphy; Eric Rohren; David P. Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M. Skibber; William Small; Constantinos T. S...; Alan P. Venook; Christopher G. Wi...; Deborah A. Freedm...; Kristina M. Gregory
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Rectal Neoplasms; Humans; Genetic Predisposition to Disease; Guidelines as Topic; Vitamin D; Combined Modality Therapy; Risk Assessment; Neoplasm Staging; 3. Good health

These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This discussion focuses on localized disease. The NCCN Rectal Cancer Panel believes that a multidisciplinary approach, including representation from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology, is necessary for treating patients with rectal cancer.